VanEck Associates’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,916
| Closed | -$18K | – | 1407 |
|
|
2024
Q1 | $18K | Buy |
4,916
+506
| +11% | +$1.85K | ﹤0.01% | 1318 |
|
|
2023
Q4 | $43K | Buy |
4,410
+917
| +26% | +$8.94K | ﹤0.01% | 1293 |
|
|
2023
Q3 | $29K | Buy |
3,493
+374
| +12% | +$3.11K | ﹤0.01% | 1317 |
|
|
2023
Q2 | $41K | Buy |
3,119
+351
| +13% | +$4.61K | ﹤0.01% | 1311 |
|
|
2023
Q1 | $32K | Buy |
2,768
+303
| +12% | +$3.5K | ﹤0.01% | 1333 |
|
|
2022
Q4 | $20K | Buy |
2,465
+686
| +39% | +$5.57K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $10K | Buy |
+1,779
| New | +$10K | ﹤0.01% | 1338 |
|